omega-n-methylarginine has been researched along with brl 37344 in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (brl 37344) | Trials (brl 37344) | Recent Studies (post-2010) (brl 37344) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 290 | 0 | 46 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | brl 37344 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 5 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.8697 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balligand, JL; Bril, A; Gauthier, C; Khandoudi, N; Kobzik, L; Le Marec, H; Leblais, V; Trochu, JN | 1 |
1 other study(ies) available for omega-n-methylarginine and brl 37344
| Article | Year |
|---|---|
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Topics: Adrenergic beta-Agonists; Arginine; Cyclic GMP; Ethanolamines; Female; Heart; Heart Ventricles; Humans; Isoproterenol; Kinetics; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; Norepinephrine; omega-N-Methylarginine; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3 | 1998 |